Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone
We present the case report of a patient with severe polycythaemia associated with tibolone. In our 65-year-old postmenopausal patient who initially presented with haemoglobin 203 g/L [115–160] and haematocrit 0.63 [0.32–0.47], the cessation of tibolone, a synthetic hormone replacement therapy, led t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2017/3476349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568071108165632 |
|---|---|
| author | Laura Staples Tamara Milder Philip Young-Ill Choi |
| author_facet | Laura Staples Tamara Milder Philip Young-Ill Choi |
| author_sort | Laura Staples |
| collection | DOAJ |
| description | We present the case report of a patient with severe polycythaemia associated with tibolone. In our 65-year-old postmenopausal patient who initially presented with haemoglobin 203 g/L [115–160] and haematocrit 0.63 [0.32–0.47], the cessation of tibolone, a synthetic hormone replacement therapy, led to a dramatic and sustained resolution of this patient’s polycythaemia to normal haematological values. Tibolone possesses oestrogenic, androgenic, and progestogenic properties. Tibolone therapy may be an infrequently recognized contributor towards polycythaemia in postmenopausal patients presenting to haematology clinics. |
| format | Article |
| id | doaj-art-4a406bf699c64e978afe124ea1f8e077 |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-4a406bf699c64e978afe124ea1f8e0772025-02-03T00:59:45ZengWileyCase Reports in Hematology2090-65602090-65792017-01-01201710.1155/2017/34763493476349Polycythaemia Secondary to Hormone Replacement Therapy with TiboloneLaura Staples0Tamara Milder1Philip Young-Ill Choi2Haematology Department, The Canberra Hospital, Canberra, ACT, AustraliaEndocrinology Department, The Canberra Hospital, Canberra, ACT, AustraliaHaematology Department, The Canberra Hospital, Canberra, ACT, AustraliaWe present the case report of a patient with severe polycythaemia associated with tibolone. In our 65-year-old postmenopausal patient who initially presented with haemoglobin 203 g/L [115–160] and haematocrit 0.63 [0.32–0.47], the cessation of tibolone, a synthetic hormone replacement therapy, led to a dramatic and sustained resolution of this patient’s polycythaemia to normal haematological values. Tibolone possesses oestrogenic, androgenic, and progestogenic properties. Tibolone therapy may be an infrequently recognized contributor towards polycythaemia in postmenopausal patients presenting to haematology clinics.http://dx.doi.org/10.1155/2017/3476349 |
| spellingShingle | Laura Staples Tamara Milder Philip Young-Ill Choi Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone Case Reports in Hematology |
| title | Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone |
| title_full | Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone |
| title_fullStr | Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone |
| title_full_unstemmed | Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone |
| title_short | Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone |
| title_sort | polycythaemia secondary to hormone replacement therapy with tibolone |
| url | http://dx.doi.org/10.1155/2017/3476349 |
| work_keys_str_mv | AT laurastaples polycythaemiasecondarytohormonereplacementtherapywithtibolone AT tamaramilder polycythaemiasecondarytohormonereplacementtherapywithtibolone AT philipyoungillchoi polycythaemiasecondarytohormonereplacementtherapywithtibolone |